D. E. Shaw & Co., Inc.

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$44,722,582

-$10,776,309 QoQ

Shares Held

710,559

-10.2% QoQ

Ownership

1.62%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#19

of 256 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. TARS ranks #28 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,877,959	$626,707,987
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,104,109	$332,369,932
3	EXEL	Exelixis, Inc.	5,551,747	$302,070,554
4	BBIO	BridgeBio Pharma, Inc.	3,633,007	$270,586,360
5	TGTX	Tg Therapeutics, Inc.	3,400,808	$186,840,390
6	HALO	Halozyme Therapeutics, Inc.	2,006,479	$157,047,110
7	AXSM	Axsome Therapeutics, Inc.	604,753	$148,025,391
8	PTCT	Ptc Therapeutics, Inc.	1,548,919	$126,345,322

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$44,722,582	710,559	-10.2%	Shares	Defined	2026-08-14
2026-03-31	$55,498,891	791,146	+28.6%	Shares	Defined	2026-05-15
2025-12-31	$50,368,972	615,156	+2.8%	Shares	Defined	2026-02-17
2025-09-30	$35,557,384	598,307	-17.3%	Shares	Defined	2025-11-14
2025-06-30	$29,296,142	723,183	+76.1%	Shares	Defined	2025-08-14
2025-03-31	$21,096,426	410,676	+12.3%	Shares	Defined	2025-05-15
2024-12-31	$20,240,171	365,544	+100.7%	Shares	Defined	2025-02-14
2024-09-30	$5,989,103	182,095	-32.5%	Shares	Defined	2024-11-14
2024-06-30	$7,332,973	269,793	+37.3%	Shares	Defined	2024-08-14
2024-03-31	$7,143,211	196,512	+384.9%	Shares	Defined	2024-05-15
2023-12-31	$820,671	40,527	+72.8%	Shares	Defined	2024-02-14
2023-06-30	$423,759	23,451	+33.5%	Shares	Defined	2023-08-14
2023-03-31	$220,817	17,567	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.